TY - JOUR
T1 - Purification of bionanoparticles
AU - Pedro, Luísa
AU - Soares, Sandra S.
AU - Ferreira, Guilherme N.M.
PY - 2008/6/1
Y1 - 2008/6/1
N2 - The recent demand for nanoparticulate products such as viruses, plasmids, protein nanoparticles, and drug delivery systems have resulted in the requirement for predictable and controllable production processes. Protein nanoparticles are an attractive candidate for gene and molecular therapy due to their relatively easy production and manipulation. These particles combine the advantages of both viral and non-viral vectors while minimizing the disadvantages. However, their successful application depends on the availability of selective and scalable methodologies for product recovery and purification. Downstream processing of nanoparticles depends on the production process, producer system, culture media and on the structural nature of the assembled nanoparticle, i.e., mainly size, shape and architecture. In this paper, the most common processes currently used for the purification of nanoparticles, are reviewed.
AB - The recent demand for nanoparticulate products such as viruses, plasmids, protein nanoparticles, and drug delivery systems have resulted in the requirement for predictable and controllable production processes. Protein nanoparticles are an attractive candidate for gene and molecular therapy due to their relatively easy production and manipulation. These particles combine the advantages of both viral and non-viral vectors while minimizing the disadvantages. However, their successful application depends on the availability of selective and scalable methodologies for product recovery and purification. Downstream processing of nanoparticles depends on the production process, producer system, culture media and on the structural nature of the assembled nanoparticle, i.e., mainly size, shape and architecture. In this paper, the most common processes currently used for the purification of nanoparticles, are reviewed.
KW - Bionanoparticles
KW - Downstream processing
KW - Gene therapy
UR - http://www.scopus.com/inward/record.url?scp=46049101232&partnerID=8YFLogxK
U2 - 10.1002/ceat.200800176
DO - 10.1002/ceat.200800176
M3 - Review article
AN - SCOPUS:46049101232
SN - 0930-7516
VL - 31
SP - 815
EP - 825
JO - Chemical Engineering and Technology
JF - Chemical Engineering and Technology
IS - 6
ER -